| scholarly article | Q13442814 |
| P50 | author | Suzanne Bertera | Q51125093 |
| P2093 | author name string | Kai W Wucherpfennig | |
| Massimo Trucco | |||
| Adrian E Morelli | |||
| Adriana T Larregina | |||
| Angela Montecalvo | |||
| Sherrie J Divito | |||
| William J Shufesky | |||
| Linda G Baum | |||
| Marcelo J Perone | |||
| Nilufer Seth | |||
| Alicia R Mathers | |||
| Mabel Pang | |||
| P2860 | cites work | Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1 | Q28144624 |
| The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity | Q28281686 | ||
| Galectins: a new family of regulators of inflammation | Q30616505 | ||
| Immunology of type 1 diabetes. Intervention and prevention strategies | Q33802790 | ||
| Corpse clearance defines the meaning of cell death | Q33922730 | ||
| In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice | Q34224719 | ||
| Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? | Q34693483 | ||
| Overview of prevention and intervention trials for type 1 diabetes | Q35583872 | ||
| Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells | Q35669757 | ||
| A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. | Q35792141 | ||
| The NOD mouse: a model of immune dysregulation | Q36072434 | ||
| A comprehensive review of interventions in the NOD mouse and implications for translation | Q36235741 | ||
| Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes | Q36367942 | ||
| Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis | Q36375186 | ||
| Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes | Q36377257 | ||
| In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 | ||
| CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 | ||
| Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production | Q36446935 | ||
| Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death | Q38336667 | ||
| The S-type lectin from calf heart tissue binds selectively to the carbohydrate chains of laminin | Q38339692 | ||
| Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration | Q40293926 | ||
| Preparation of Recombinant Human Galectin-1 and Use in T-Cell Death Assays | Q40622858 | ||
| Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction | Q40848658 | ||
| CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death | Q40860984 | ||
| Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death | Q41982710 | ||
| Regulated expression and ultrastructural localization of galectin-1, a proapoptotic beta-galactoside-binding lectin, during spermatogenesis in rat testis. | Q42434910 | ||
| Expression of the L14 lectin during mouse embryogenesis suggests multiple roles during pre- and post-implantation development | Q42612637 | ||
| Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis | Q43820997 | ||
| Galectin-1 suppresses experimental colitis in mice | Q44429812 | ||
| Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone | Q44534362 | ||
| Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response | Q45147481 | ||
| Amelioration of graft versus host disease by galectin-1. | Q45993478 | ||
| Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice | Q46168391 | ||
| Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation | Q46250141 | ||
| Apoptosis of T cells mediated by galectin-1. | Q46356564 | ||
| A pivotal role for galectin-1 in fetomaternal tolerance | Q46891030 | ||
| Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix | Q46915611 | ||
| Ex Vivo Analysis of Thymic CD4 T Cells in Nonobese Diabetic Mice with Tetramers Generated from I-Ag7/Class II-Associated Invariant Chain Peptide Precursors | Q47581749 | ||
| Enhanced apoptotic activity of a structurally optimized form of galectin-1. | Q47612279 | ||
| Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege | Q47860342 | ||
| Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. | Q51103369 | ||
| Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. | Q51125043 | ||
| Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells. | Q51187673 | ||
| Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. | Q51468524 | ||
| Immunohistochemical localization of a beta-galactoside-binding lectin in rat central nervous system. I. Light- and electron-microscopical studies on developing cerebral cortex and corpus callosum. | Q52247942 | ||
| Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. | Q53624752 | ||
| Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death | Q56169018 | ||
| Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. | Q64985920 | ||
| Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice | Q68123525 | ||
| Altered cytokine activity in adjuvant inhibition of autoimmune diabetes | Q70477284 | ||
| Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells | Q70983849 | ||
| Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors | Q72208453 | ||
| Tissue fibronectin is an endogenous ligand for galectin-1 | Q72310370 | ||
| Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice | Q73401711 | ||
| Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions | Q73567384 | ||
| Evidence of a role for galectin-1 in acute inflammation | Q73812480 | ||
| A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice | Q73896300 | ||
| Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 | Q78127337 | ||
| Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking | Q81509186 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2641-2653 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Suppression of autoimmune diabetes by soluble galectin-1 | |
| P478 | volume | 182 |
| Q38081185 | 'Sweetening' pregnancy: galectins at the fetomaternal interface |
| Q84734368 | Absence of Galectin-1 accelerates CD8⁺ T cell-mediated graft rejection |
| Q38317758 | Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function |
| Q34508281 | An update on the use of NOD mice to study autoimmune (Type 1) diabetes |
| Q38071420 | Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus. |
| Q40170463 | Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy |
| Q38071660 | Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target |
| Q34660346 | Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes |
| Q34192497 | Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation |
| Q42407157 | Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology |
| Q37107168 | Engineering galectin-glycan interactions for immunotherapy and immunomodulation |
| Q42694566 | Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis |
| Q37862237 | Galectin-1 and immunotherapy for brain cancer. |
| Q54453651 | Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors. |
| Q44843923 | Galectin-1 promotes human neutrophil migration |
| Q35917620 | Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions |
| Q26825120 | Galectin-1 research in T cell immunity: past, present and future |
| Q42568683 | Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression |
| Q36946903 | Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology |
| Q47381420 | Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation |
| Q52353649 | Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients. |
| Q35824985 | Galectins in hematological malignancies. |
| Q35180105 | Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppression |
| Q37773304 | Immunotherapy with regulatory T cells in transplantation. |
| Q37809484 | In search of a solution to the sphinx-like riddle of GM1. |
| Q83674724 | Increased galectin-1 expression in muscle of Astragalus polysaccharide-treated Type 1 diabetic mice |
| Q39308744 | Inhibitory effects of the transcription factor Ets-1 on the expression of type I collagen in TGF-β1-stimulated renal epithelial cells |
| Q36049534 | Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes |
| Q55337327 | Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes. |
| Q27336019 | Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis |
| Q38193734 | Possible novel biomarkers of organ involvement in systemic lupus erythematosus |
| Q54285103 | Reduced expression of galectin-1 and galectin-9 by leucocytes in asthma patients. |
| Q39377433 | Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma |
| Q90244601 | Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits |
| Q39657596 | Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells |
| Q42827891 | Targeted inhibition of galectin 1 by thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats. |
| Q34983677 | Testing agents for prevention or reversal of type 1 diabetes in rodents |
| Q55349770 | The Role of Galectins as Modulators of Metabolism and Inflammation. |
| Q26750877 | The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression |
| Q54189348 | The effects of galectin-1 on the gene expression of the transcription factors TBX21, GATA-3, FOXP3 and RORC. |
| Q36906422 | The regulatory power of glycans and their binding partners in immunity |
| Q38945365 | Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease |
| Q37443866 | Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation |
| Q61445616 | Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive Project |
Search more.